Ameliorative Effects of Bredemolic Acid on Markers Associated with Renal Dysfunction in a Diet-Induced Prediabetic Rat Model

Oxid Med Cell Longev. 2020 Jun 22:2020:2978340. doi: 10.1155/2020/2978340. eCollection 2020.

Abstract

Recently, studies have shown that renal dysfunction is associated not only with overt diabetes but also with the preceding stage known as prediabetes. Diet and pharmacological interventions are the therapeutic approaches to managing prediabetes, but the compliance in combining the two interventions is low. Hence, the efficacy of pharmacological intervention is reduced without diet modification. In our previous study, we established that bredemolic acid (BA) ameliorated glucose homeostasis via increased GLUT 4 expression in the skeletal muscle of prediabetic rats in the absence of diet intervention. However, the effects of bredemolic acid on renal function in prediabetic condition are unknown. Therefore, this study was aimed at investigating the ameliorative effects of bredemolic acid on renal dysfunction in a diet-induced prediabetic rat model. Thirty-six Sprague-Dawley male rats (150-180 g) were divided into two groups: the nonprediabetic (n = 6) and prediabetic (n = 30) groups which were fed normal diet (ND) and high-fat high-carbohydrate (HFHC) diet, respectively, for 20 weeks. After the 20th week, the prediabetic groups were subdivided into prediabetic control (PD) and 4 other prediabetic groups which were treated with either BA (80 mg/kg) or metformin (MET, 500 mg/kg) for further 12 weeks (21st to 32nd). Plasma, urine, and kidney samples were collected for biochemical analysis. The untreated prediabetic (PD) rats presented increased fluid intake and urine output; increased creatinine, urea, and uric acid plasma concentrations; albuminuria; proteinuria; sodium retention; potassium loss; increased aldosterone and kidney injury molecule (KIM-1) concentration; and increased urinary podocin mRNA expression. However, BA administration attenuated the renal markers and oxidative stress and decreased the urinary podocin mRNA expression. In conclusion, BA administration, regardless of diet modification, attenuates renal dysfunction in an experimentally induced prediabetic state.

MeSH terms

  • Animals
  • Antioxidants / metabolism
  • Antioxidants / therapeutic use*
  • Biomarkers / blood
  • Biomarkers / urine
  • Diet / adverse effects*
  • Disease Models, Animal
  • Hypoglycemic Agents / therapeutic use
  • Intracellular Signaling Peptides and Proteins / urine
  • Kidney / drug effects
  • Kidney / metabolism
  • Kidney / physiopathology
  • Kidney Diseases / drug therapy*
  • Kidney Diseases / etiology
  • Kidney Diseases / physiopathology
  • Lipid Peroxidation / drug effects
  • Male
  • Membrane Proteins / urine
  • Metformin / therapeutic use
  • Prediabetic State / drug therapy*
  • Prediabetic State / etiology
  • Prediabetic State / physiopathology
  • Rats
  • Rats, Sprague-Dawley
  • Triterpenes / therapeutic use*

Substances

  • Antioxidants
  • Biomarkers
  • Hypoglycemic Agents
  • Intracellular Signaling Peptides and Proteins
  • Membrane Proteins
  • NPHS2 protein
  • Triterpenes
  • Metformin
  • maslinic acid